Your Complete Guide to Global Clinical Research and GCP Compliance
Using Statistical Analysis Plan (SAP) & DMC Charter to Strengthen Submission Packages and Health Authority Reviews In the realm of clinical research, especially in precision medicine clinical trials, the importance of rigorous data management and analysis cannot be overstated. This tutorial aims to provide a comprehensive guide on how to develop a robust Statistical Analysis…
Governance Forums for Ongoing Review of Systemic Compliance Risk Governance Forums for Ongoing Review of Systemic Compliance Risk In the rapidly evolving landscape of clinical research, maintaining compliance with regulatory requirements is paramount. For clinical operations, regulatory affairs, and medical affairs professionals, understanding the nuances of compliance, particularly in the context of iit clinical trials,…
Read More “Governance Forums for Ongoing Review of Systemic Compliance Risk” »
Training Leaders to Recognize Early Signs of Systemic Non-Compliance Training Leaders to Recognize Early Signs of Systemic Non-Compliance In the ever-evolving landscape of clinical trials, the integrity of data and adherence to protocols is paramount. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals on how to recognize…
Read More “Training Leaders to Recognize Early Signs of Systemic Non-Compliance” »
Training Clinical, Regulatory and Medical Teams on Device & Diagnostic Transparency Training Clinical, Regulatory and Medical Teams on Device & Diagnostic Transparency The increasing complexity and sophistication of medical devices and diagnostics present significant challenges for clinical research professionals. Ensuring transparency in clinical trials is vital for regulatory compliance and public trust. This article serves…
Read More “Training Clinical, Regulatory and Medical Teams on Device & Diagnostic Transparency” »
Using Device & Diagnostic Transparency to Support Publications, HTA and Market Access Using Device & Diagnostic Transparency to Support Publications, HTA and Market Access In the rapidly evolving landscape of clinical research, device and diagnostic transparency has emerged as a critical component for supporting scientific publications, health technology assessments (HTAs), and successful market access. This…
Read More “Using Device & Diagnostic Transparency to Support Publications, HTA and Market Access” »
Templates, Checklists and Governance Models for Robust Statistical Analysis Plan (SAP) & DMC Charter In the conduct of clinical trials, particularly in the context of eCRF clinical trials, the creation of a comprehensive Statistical Analysis Plan (SAP) and Data Monitoring Committee (DMC) Charter is a fundamental aspect related to regulatory compliance and overall study success….
Systemic Non-Compliance in DCT, Vendor Oversight and Digital Systems Compliance with regulatory standards is crucial in clinical trials, especially for Phase I studies where pharmacokinetics (PK) are evaluated. With the rise of decentralized clinical trials (DCT), understanding systemic non-compliance, vendor oversight, and digital systems has become paramount for clinical operations, regulatory affairs, and medical affairs…
Read More “Systemic Non-Compliance in DCT, Vendor Oversight and Digital Systems” »
Documenting Rationale When Non-Compliance Is Deemed Isolated In the rigorous environment of clinical trials, maintaining compliance with regulatory requirements is paramount. Understanding how to document and categorize non-compliance—especially when it is deemed isolated—is crucial for clinical operations, regulatory affairs, and medical affairs professionals. This guide offers a comprehensive, step-by-step tutorial aimed at navigating the complexities…
Read More “Documenting Rationale When Non-Compliance Is Deemed Isolated” »
Integrating Device & Diagnostic Transparency With Data Privacy, GDPR and HIPAA Requirements Integrating Device & Diagnostic Transparency With Data Privacy, GDPR and HIPAA Requirements In the intricate landscape of clinical trials, the integration of device and diagnostic transparency with a robust understanding of data privacy laws is paramount. With coverage across the US, UK, and…
Vendor and Partner Oversight Considerations for Device & Diagnostic Transparency Vendor and Partner Oversight Considerations for Device & Diagnostic Transparency Device and diagnostic transparency in clinical trials is crucial as it assures the integrity of data and enhances public confidence in clinical research. Effective oversight of vendors and partners involved in these studies is a…
Read More “Vendor and Partner Oversight Considerations for Device & Diagnostic Transparency” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.